P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL

• K. Rejeski,
• O. Albanyan,
• G. Iacoboni,
• V. Bücklein,
• V. Blumenberg,
• O. Penack,
• W. Bethge,
• S. Völkl,
• A. Perez,
• C. Carpio,
• C. Schmidt,
• N. Müller,
• K. Reid,
• R. Faramand,
• M. Davila,
• L. Bullinger,
• F. Locke,
• M. von Bergwelt-Baildon,
• A. Mackensen,
• P. Barba,
• M. Jain,
• M. Subklewe

Affiliations

K. Rejeski

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

O. Albanyan

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

G. Iacoboni

5 Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona

V. Bücklein

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

V. Blumenberg

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

O. Penack

7 Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin

W. Bethge

8 Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen

S. Völkl

9 Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany

A. Perez

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

C. Carpio

5 Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona

C. Schmidt

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

N. Müller

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

K. Reid

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

R. Faramand

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

M. Davila

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

L. Bullinger

7 Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, Berlin

F. Locke

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

M. von Bergwelt-Baildon

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital

A. Mackensen

9 Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen-Nuremberg, Erlangen, Germany

P. Barba

5 Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona

M. Jain

4 Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, United States of America

M. Subklewe

1 Department of Medicine III - Hematology/Oncology, LMU University Hospital